Business
Acquisition of Health & Her Limited
Acquisition of Health & Her Limited.
About this update from Venture Life Group Plc
[{"type":"text","content":"\n\nThis Announcement contains inside information as defined for the purposes of Article 7 of the Market Abuse Regulation (EU no. 596/2014), as it forms part of the United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended. This announcement has been authorised for release by the Company's Board of Directors.\n \n30 October 2024\n \n\n \nVENTURE LIFE GROUP PLC\n(\"Venture Life\", \"VLG\" or the \"Group\")\n \nAcquisition of Health & Her Limited\n \nVenture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, is pleased to announce the acquisition of the entire issued share capital of Health & Her Limited (\"H&H\"), a specialist female health business from its founders, Kate Bache and Gervase Fay (the \"Founders\") and other shareholders, for an upfront cash consideration of £7.5m. A further £0.7m in cash is payable 12 months post completion, dependent upon the Founders remaining with the business for at least 12 months, with an additional £1.8m of consideration payable in cash contingent upon H&H achieving expected trading results for the 12 months post completion.\n \nH&H, headquartered in Cardiff and founded in 2018, is a brand currently predominantly focused on female health, specifically the transitional elements of hormone health, providing supplements and digital support for the female hormonal health journey. Whilst their menopause and peri-menopause products currently constitute the majority of the business's revenue, the business has extended its offering further and will shortly be launching new products in the female hormonal health area and also into the area of male hormonal health. H&H is a leading brand in hormonal wellbeing supplements, and offers a free educational app to support holistic health. The H&H app is the world's second-largest menopause app, the No.1 menopause app recommended by ORCHA, and the first to publish its impact on menopausal health (British Medical Journal).\n \nThe global menopause market was estimated at $16bn in 2023 (by Grand View Research), but Forbes Magazine estimates it to rise to $600bn by 2030, demonstrating substantial market growth over the next 7 years, meaning the current product range is selling into a r...